Leiden mutation in patients with Crohn's disease

Inflammopharmacology

Volumn 7, Issue 3, 1999, Pages 297-301

  Nagy, Zs ^a   Nagy, A ^a   Karadi, O ^a   Figler, M ^a   Suto, G ^a   Vincze, A ^a   Par, A ^a   Mozsik, Gy ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Crohn's disease; Leiden mutation

Indexed keywords

FIBRINOGEN; LUPUS ANTICOAGULANT; PROTEIN C;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE MUTATION; HEMATOLOGICAL PARAMETERS; HUMAN; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; THROMBOSIS;

EID: 0033429113     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-999-0013-0     Document Type: Review

References (22)

1. J. A. Bargen N. W. Barker 1936 Extensive arterial and venous thrombosis complicating chronic ulcerative colitis Arch. Intern. Med. 58 17 31 Bargen, J. A. and Barker, N. W. (1936). Extensive arterial and venous thrombosis complicating chronic ulcerative colitis, Arch. Intern. Med. 58, 17–31.
2. R. M. Bertina B. P. Koeleman T. Koster F. R. Rosendaal R. J. Dirven H Ronde de P. A. Velden van der H. P. Reitsma 1994 Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 64 67 8164741 10.1038/369064a0 1:CAS:528:DyaK2cXktVKnt7c%3D Bertina, R. M., Koeleman, B. P., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A. and Reitsma, H. P. (1994). Mutation in blood coagulation factor V associated with resistance to activated protein C, Nature 369, 64–67.
3. B. Dahlbäck M. Carlsson P. J. Svensson 1993 Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C Proc. Natl. Acad. Sci. USA 90 1004 1008 8430067 10.1073/pnas.90.3.1004 Dahlbäck, B., Carlsson, M. and Svensson, P. J. (1993). Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C, Proc. Natl. Acad. Sci. USA 90, 1004–1008.
4. B. Dahlbäck 1995 New molecular insights into genetics of thrombophilia: resistance to activated protein C caused by Arg506 to Glu mutation of factor V as a pathogenic risk factor for venous thrombosis Thromb. Haemost. 74 139 148 8578447 Dahlbäck, B. (1995). New molecular insights into genetics of thrombophilia: resistance to activated protein C caused by Arg506 to Glu mutation of factor V as a pathogenic risk factor for venous thrombosis, Thromb. Haemost. 74, 139–148.
5. M. H. Denninger K. Beldjord F. Durand C. Denie D. Valla M. C. Guillin 1995 Budd-Chiari syndrome and factor V Leiden mutation Lancet 345 525 526 7861904 10.1016/S0140-6736(95)90625-8 1:STN:280:ByqC28rpsVc%3D Denninger, M. H., Beldjord, K., Durand, F., Denie, C., Valla, D. and Guillin, M. C. (1995). Budd-Chiari syndrome and factor V Leiden mutation, Lancet 345, 525–526.
6. C. Dennis K. E. Karlson 1952 Surgical measures as supplements to the management of idiopathic ulcerative colitis: cancer, cirrhosis and arthritis as frequent complications Surgery 32 892 912 13005318 1:STN:280:CyyD38bnvFQ%3D Dennis, C. and Karlson, K. E. (1952). Surgical measures as supplements to the management of idiopathic ulcerative colitis: cancer, cirrhosis and arthritis as frequent complications, Surgery 32, 892–912.
7. F. C. Edwards S. C. Truelove 1964 The course and prognosis of ulcerative colitis, Part III. Complications Gut 5 1 15 14127503 1:STN:280:CCuD1crisFA%3D Edwards, F. C. and Truelove, S. C. (1964). The course and prognosis of ulcerative colitis, Part III. Complications, Gut 5, 1–15.
8. R. L. Edwards J. B. Levine R. L. Green M Duffy E. Mathews W. Brande F. R. Rickles 1987 Activation of blood coagulation in Crohn’s disease. Increased plasma fibrinopeptide A levels an enhanced generation of monocyte tissue factor activity Gastroentemlogy 92 329 337 1:STN:280:BiiD1c7islA%3D Edwards, R. L., Levine, J. B., Green, R. L., Duffy, M, Mathews, E., Brande, W. and Rickles, F. R. (1987). Activation of blood coagulation in Crohn’s disease. Increased plasma fibrinopeptide A levels an enhanced generation of monocyte tissue factor activity, Gastroentemlogy 92, 329–337.
9. V. Graef A. H. Baggenstoss W. G. Sauer J. A., Jr. Spittell 1966 Venous thrombosis occurring in non-specific ulcerative colitis Arch. Intern. Med. 117 377 382 Graef, V., Baggenstoss, A. H., Sauer, W. G. and Spittell, J. A., Jr. (1966). Venous thrombosis occurring in non-specific ulcerative colitis, Arch. Intern. Med. 117, 377–382.
10. M. A. Heneghan B. Cleary M. Murray P. J. O’Gorman C. F. McCarthy 1998 Activated protein C resistance, thrombophilia, and inflammatory bowel disease Dig. Dis. Sci. 43 1356 1361 9635631 10.1023/A:1018892122026 1:CAS:528:DyaK1cXktFagsb0%3D Heneghan, M. A., Cleary, B., Murray, M., O’Gorman, P. J. and McCarthy, C. F. (1998). Activated protein C resistance, thrombophilia, and inflammatory bowel disease, Dig. Dis. Sci. 43, 1356–1361.
11. M. Hudson R. A. Hutton A. J. Wakefield A. M. Sawyer R. E. Pounder 1992 Evidence for activation of coagulation in Crohn’s disease Blood Coag Fibrinol. 3 773 778 10.1097/00001721-199212000-00011 1:STN:280:ByyC2cvlvFM%3D Hudson, M., Hutton, R. A., Wakefield, A. J., Sawyer, A. M. and Pounder, R. E. (1992). Evidence for activation of coagulation in Crohn’s disease, Blood Coag Fibrinol. 3, 773–778.
12. L. M. Jackson P. J. O’Gorman J. O’Conell C. C. Cronin K. P. Cotter F. Shanahan 1997 Thrombosis in inflammatory bowel disease: Clinical setting, procoagulant profile and factor V Leiden Q. J. Med. 90 183 188 1:STN:280:ByiB2cjks1w%3D Jackson, L. M., O’Gorman, P. J., O’Conell, J., Cronin, C. C., Cotter, K. P. and Shanahan, F. (1997). Thrombosis in inflammatory bowel disease: Clinical setting, procoagulant profile and factor V Leiden, Q. J. Med. 90, 183–188.
13. H. A. Liebman N. Kashani D. Sutherland W. McGehee L. Kam 1998 The factor V Leiden mutation increases the risk factor of venous thrombosis in patients with inflammatory bowel disease Gastroentemlogy 115 830 834 10.1016/S0016-5085(98)70253-7 1:STN:280:DyaK1cvis1ehsA%3D%3D Liebman, H. A., Kashani, N., Sutherland, D., McGehee, W. and Kam, L. (1998). The factor V Leiden mutation increases the risk factor of venous thrombosis in patients with inflammatory bowel disease, Gastroentemlogy 115, 830–834.
14. W. E. F. Ricketts W. L. Palmer 1946 Complications of chronic non-specific ulcerative colitis Gastroentemlogy 7 5 6 Ricketts, W. E. F. and Palmer, W. L. (1946). Complications of chronic non-specific ulcerative colitis, Gastroentemlogy 7, 5–6.
15. F. R. Rosendaal D. S. Siscovick S. M. Schwartz H. P. Reitsma 1996 Increased risk of myocardial infarction associated with factor V Leiden (APC-Resistance) among young women Blood 86 2447a 2447a Rosendaal, F. R., Siscovick, D. S., Schwartz, S. M. and Reitsma, H. P. (1996). Increased risk of myocardial infarction associated with factor V Leiden (APC-Resistance) among young women, Blood 86, 2447a.
16. W. P., Jr. Sloan J. A. Bargen R. P. Gage 1950 Life histories of patients with ulcerative colitis: a review of 2000 cases Gastroentemlogy 16 255 38 Sloan, W. P., Jr., Bargen, J. A. and Gage, R. P. (1950). Life histories of patients with ulcerative colitis: a review of 2000 cases, Gastroentemlogy 16, 255–38.
17. J. C Souto E. Martinez M. Roca J. Mateo J. Pujol D. Gonzalez J. Fontcuberta 1995 Prothrombic state and signs of endothelial lesions in plasma of patients with inflammatory bowel disease Dig. Dis. Sci. 40 1883 1889 7555437 10.1007/BF02208650 1:STN:280:BymD38bitlY%3D Souto, J. C, Martinez, E., Roca, M., Mateo, J., Pujol, J., Gonzalez, D. and Fontcuberta, J. (1995). Prothrombic state and signs of endothelial lesions in plasma of patients with inflammatory bowel disease, Dig. Dis. Sci. 40, 1883–1889.
18. T. R. J. Stevens J. P. James N. J. Simmonds D. A. McCarthy I. F Laurenson P. J. Maddison D. S. Rampton 1992 Circulating von Willebrand factor in inflammatory bowel disease Gut 33 502 506 1582595 1:STN:280:By2B2MfntlI%3D Stevens, T. R. J., James, J. P., Simmonds, N. J., McCarthy, D. A., Laurenson, I. F, Maddison, P. J. and Rampton, D. S. (1992). Circulating von Willebrand factor in inflammatory bowel disease, Gut 33, 502–506.
19. R. W. Talbot J. Heppell R. Dozois R. W. Beart 1986 Vascular complications of inflammatory bowel disease Mayo Clin. Proc. 61 140 145 3080643 1:STN:280:BimC3MjgsFU%3D Talbot, R. W., Heppell, J., Dozois, R. and Beart, R. W. (1986). Vascular complications of inflammatory bowel disease, Mayo Clin. Proc. 61, 140–145.
20. S. Warren S. C. Sommers 1949 Pathogenesis of ulcerative colitis Am. J. Pathol. 25 654 677 Warren, S. and Sommers, S. C. (1949). Pathogenesis of ulcerative colitis, Am. J. Pathol. 25, 654–677.
21. B. Zöller B. Dahlbäck 1994 Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis Lancet 343 1536 1538 7911873 10.1016/S0140-6736(94)92940-8 Zöller, B. and Dahlbäck, B. (1994). Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis, Lancet 343, 1536–1538.
22. B. Zöller P. J. Svennson X. He B. Dahlbäck 1994 Identification of the same factor V gene mutation in 47 out of 50 thrombosis prone families with inherited resistance to activated protein C J. Clin. Invest. 94 2521 2524 7989612 10.1172/JCI117623 Zöller, B., Svennson, P. J., He, X. and Dahlbäck, B. (1994). Identification of the same factor V gene mutation in 47 out of 50 thrombosis prone families with inherited resistance to activated protein C, J. Clin. Invest. 94, 2521–2524.